Entry Detail



General Information

Database ID:exR0080620
RNA Name:RPLP0
RNA Type:mRNA
Chromosome:chr12
Starnd:-
Coordinate:
Start Site(bp):120196699End Site(bp):120201235
External Links:ENSG00000089157



Disease Information

Disease Name:Fragile X Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D005600
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Fragile X Syndromes//Syndrome, Fragile X//Syndromes, Fragile X//Marker X Syndrome//Marker X Syndromes//Syndrome, Marker X//Syndromes, Marker X//Mental Retardation, X-Linked, Associated With Marxq28//X-Linked Mental Retardation and Macroorchidism//X Linked Mental Retardation and Macroorchidism//Fragile X Mental Retardation Syndrome//Martin-Bell Syndrome//Martin Bell Syndrome//Syndrome, Martin-Bell//Fra(X) Syndrome//FRAXE Syndrome//FRAXE Syndromes//Syndrome, FRAXE//Syndromes, FRAXE//Mental Retardation, X-Linked, Associated With Fragile Site Fraxe//Fragile X-F Mental Retardation Syndrome//Mar (X) Syndrome//FRAXA Syndrome//FRAXA Syndromes//Syndrome, FRAXA//Syndromes, FRAXA



Expression Detail

GEO ID:GSE83556
Description:Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions
Experimental Design:Disease vs Control
Case Disease Type:Fragile X Syndrome
Case Disease SubType:NA
Case Sample:Fragile X Syndrome
Control Sample:Normal
Number of Case:22
Number of Control:18
Number of Samples:40





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC092718.3
chr16
81053587
81096296
-
AC007192.1
chr19
18153158
18178117
+
AC091167.2
chr15
90249556
90272208
+
AC138811.2
chr16
18788063
18801519
-
ACTR3
chr2
113890063
113962596
+
ADGRA3
chr4
22345071
22516066
-
ACTR5
chr20
38748460
38772520
+
AL121594.1
chr14
35122549
35317474
+
AGPAT5
chr8
6708642
6761503
+
AARS2
chr6
44298731
44313347
-
AGPAT3
chr21
43865223
43987592
+
AL132671.2
chr6
117318211
117573571
-
AC010422.3
chr19
12643831
12648397
-
AL022238.4
chr22
40346529
40410054
+
AK3
chr9
4709556
4742043
-
ADNP
chr20
50888916
50931437
-
AC010323.1
chr19
8308283
8321379
-
ABCF1
chr6
30571393
30597179
+
AHCYL1
chr1
109984765
110023742
+
AC011455.2
chr19
38915404
38949855
-
AL136295.1
chr14
24189157
24213473
-
AC011511.1
chr19
10305427
10316009
-
AC006064.6
chr12
6556886
6607367
-
AC005832.4
chr12
4604944
4662643
+
ACTG1
chr17
81509971
81523847
-
AC010463.1
chr19
17267418
17282966
+
AL133352.1
chr10
100505628
100529881
-
AKT1
chr14
104769349
104795751
-
AL928654.3
chr14
105487199
105492267
+
ACAT1
chr11
108116695
108147603
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-3609
chr7
98881700
98881723
+
hsa-miR-4426
chr1
192716333
192716349
+
hsa-miR-6833-3p
chr6
32179856
32179876
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC002470.2
chr22
20979462
20998121
+
AC007952.4
chr17
19112000
19112636
-
AC008937.3
chr5
56927874
56929573
+
AC010542.4
chr16
66549280
66551189
+
AC010642.2
chr19
58309727
58327248
-
AC010655.2
chr7
128455937
128469197
+
AC010655.4
chr7
128455840
128493859
+
AC010733.2
chr2
60925909
60931610
+
AC020910.5
chr19
34733298
34733837
-
AC023509.1
chr12
53441741
53467528
+
AC026362.1
chr12
122975320
122982907
+
AC064802.1
chr8
114282067
114295839
+
AC068768.1
chr12
123262060
123262402
+
AC073896.4
chr12
56162359
56190284
-
AC104109.4
chr5
134205614
134371044
-
AC105036.3
chr15
75527150
75601205
-
AC109460.3
chr16
28974804
28990775
+
AC147651.4
chr7
603185
608482
+
AD000090.1
chr19
35557956
35581954
+
ADD3-AS1
chr10
109940104
110008381
-
AL022311.1
chr22
37876148
37895563
+
Display:



Experiment Detail

GEO ID:GSE83556
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:RNA was extracted from 5-15 mL amniotic fluid supernatant (centrifugation at 350g, 4C, 10, min).
RNA Extract protocol:All samples were processed using the Qiagen Circulating Nucleic Acid kit with an on-column DNase digestion step to remove genomic DNA. The RNA was then purified and concentrated with the RNeasy MinElute Clean up kit and eluted in RNasefree water.
RNA library preparation protocol:RNA was converted to cDNA and amplified using the Ovation Pico WTA kit V2 and then purified with the QIAquick PCR Purification kit. Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA)Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA